OxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway

Thrombosis Research

Volumn 134, Issue 2, 2014, Pages 384-392

  Xu, Ya ^a,b,c   Kong, Xiangmin ^b   Zhou, Hong ^a,b   Zhang, Xiaolei ^b   Liu, Jingjing ^b   Yan, Jinchuan ^a   Xie, Hongxiang ^b   Xie, Yachao ^b  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

foam cell; MCP 1; NF B; oxLDL 2GPI anti 2GPI complex; TF; TLR4

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PYRROLIDINE DITHIOCARBAMATE; RESATORVID; THROMBOPLASTIN; TOLL LIKE RECEPTOR 4; BETA2 GLYCOPROTEIN 1; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CONTROLLED STUDY; FOAM CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CYTOLOGY; IMMUNOLOGY;

ANIMALS; BETA 2-GLYCOPROTEIN I; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINE CCL2; FOAM CELLS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84905117046     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.05.017     Document Type: Article

References (51)

1. J.R. Ward, H.L. Wilson, S.E. Francis, D.C. Crossman, and I. Sabroe Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease Clin Exp Immunol 156 2009 386 394
2. M. Dessi, A. Noce, P. Bertucci, S. Manca di Villahermosa, R. Zenobi, and V. Castagnola et al. Atherosclerosis, Dyslipidemia, and Inflammation: The Significant Role of Polyunsaturated Fatty Acids ISRN Inflamm 2013 1918 1923
3. Y. Shoenfeld, R. Gerli, A. Doria, E. Matsuura, M.M. Cerinic, and N. Ronda et al. Accelerated atherosclerosis in autoimmune rheumatic diseases Circulation 112 2005 3337 3347
4. E. Matsuura, and L.R. Lopez Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis? Clin Dev Immunol 11 2004 103 111
5. K. Kobayashi, L.R. Lopez, Y. Shoenfeld, and E. Matsuura The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis Ann N Y Acad Sci 1051 2005 442 454
6. E. Matsuura, K. Kobayashi, B.L. Hurley, and L.R. Lopez Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome Lupus 15 2006 478 483
7. K. Kobayashi, K. Tada, H. Itabe, T. Ueno, P.H. Liu, and A. Tsutsumi et al. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages Lupus 16 2007 929 938
8. P.G. de Groot, and R.T. Urbanus The future of antiphospholipid antibody testing Semin Thromb Hemost 38 2012 412 420
9. G. Xu, H. Wen, H. Zhou, D. Guo, F. Zhou, and D. Chen et al. Involvement of IRAKs and TRAFs in anti-beta(2)GPI/beta(2)GPI-induced tissue factor expression in THP-1 cells Thromb Haemost 106 2011 1158 1169
10. P.G. de Groot, and R.T. Urbanus The significance of autoantibodies against beta2-glycoprotein I Blood 120 2012 266 274
11. A. Arad, V. Proulle, R.A. Furie, B.C. Furie, and B. Furie beta(2)-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model Blood 117 2011 3453 3459
12. K.L. Allen, F.V. Fonseca, V. Betapudi, B. Willard, J. Zhang, and K.R. McCrae A novel pathway for human endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies Blood 119 2012 884 893
13. E. Matsuura, G.R. Hughes, and M.A. Khamashta Oxidation of LDL and its clinical implication Autoimmun Rev 7 2008 558 566
14. K. Kobayashi, E. Matsuura, Q. Liu, J. Furukawa, K. Kaihara, and J. Inagaki et al. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages J Lipid Res 42 2001 697 709
15. K. Kobayashi, M. Kishi, T. Atsumi, M.L. Bertolaccini, H. Makino, and N. Sakairi et al. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen J Lipid Res 44 2003 716 726
16. N. Bassi, S. Zampieri, A. Ghirardello, M. Tonon, M. Zen, and S. Beggio et al. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates Autoimmunity 42 2009 289 291
17. J. George, D. Harats, B. Gilburd, A. Afek, Y. Levy, and J. Schneiderman et al. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression Circulation 05/05/1999 2227 2230 [ed1999]
18. E. Matsuura, K. Kobayashi, M. Tabuchi, and L.R. Lopez Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis Prog Lipid Res 45 2006 466 486
19. R. Ostuni, I. Zanoni, and F. Granucci Deciphering the complexity of Toll-like receptor signaling Cell Mol Life Sci 67 2010 4109 4134
20. E. Matsuura, L.R. Lopez, Y. Shoenfeld, and P.R. Ames beta2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity? Autoimmun Rev 12 2012 241 249
21. Y.C. Lu, W.C. Yeh, and P.S. Ohashi LPS/TLR4 signal transduction pathway Cytokine 42 2008 145 151
22. H. Geng, A. Wang, G. Rong, B. Zhu, Y. Deng, and J. Chen et al. The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway Mol Cell Biochem 342 2010 201 206
23. K.W. Howell, X. Meng, D.A. Fullerton, C. Jin, T.B. Reece, and J.C. Cleveland Jr. Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells J Surg Res 171 2011 e27 e31
24. M. Higashimori, J.B. Tatro, K.J. Moore, M.E. Mendelsohn, J.B. Galper, and D. Beasley Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 31 2011 50 57
25. X.H. Xu, P.K. Shah, E. Faure, O. Equils, L. Thomas, and M.C. Fishbein et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL Circulation 104 2001 3103 3108
26. L. Xia, H. Zhou, L. Hu, H. Xie, T. Wang, and Y. Xu et al. Both NF-kappaB and c-Jun/AP-1 involved in anti-beta2GPI/beta2GPI-induced tissue factor expression in monocytes Thromb Haemost 109 2013 643 651
27. H. Xie, H. Zhou, H. Wang, D. Chen, L. Xia, and T. Wang et al. Anti-beta(2)GPI/beta(2)GPI induced TF and TNF-alpha expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways Mol Immunol 53 2013 246 254
28. H. Zhou, D. Chen, H. Xie, L. Xia, T. Wang, and W. Yuan et al. Activation of MAPKs in the anti-beta2GPI/beta2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells Thromb Res 130 2012 e229 e235
29. Y. Murase, J. Kobayashi, A. Nohara, A. Asano, N. Yamaaki, and K. Suzuki et al. Raloxifene promotes adipocyte differentiation of 3 T3-L1 cells Eur J Pharmacol 538 2006 1 4
30. C. Weber, and H. Noels Atherosclerosis: current pathogenesis and therapeutic options Nat Med 17 2011 1410 1422
31. E. Matsuura, K. Kobayashi, T. Yasuda, and T. Koike Antiphospholipid antibodies and atherosclerosis Lupus 7 Suppl. 2 1998 S135 S139
32. C.A. Roldan, J. Joson, J. Sharrar, C.R. Qualls, and W.L. Sibbitt Jr. Premature aortic atherosclerosis in systemic lupus erythematosus: a controlled transesophageal echocardiographic study J Rheumatol 37 2010 71 78
33. C.A. Muniz Caldas, and J. Freire de Carvalho Cardiovascular comorbidities in antiphospholipid syndrome Expert Rev Clin Immunol 9 2013 987 990
34. P.R. Ames, C. Tommasino, J. Alves, J.D. Morrow, L. Iannaccone, and G. Fossati et al. Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study Lupus 9 2000 688 695
35. B. Nowak, M. Szmyrka-Kaczmarek, A. Durazinska, R. Plaksej, K. Borysewicz, and L. Korman et al. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus Adv Clin Exp Med 21 2012 331 335
36. K. Kobayashi, L.R. Lopez, and E. Matsuura Atherogenic antiphospholipid antibodies in antiphospholipid syndrome Ann N Y Acad Sci 1108 2007 489 496
37. E. Matsuura, and L.R. Lopez Autoimmune-mediated atherothrombosis Lupus 17 2008 878 887
38. S. Bhaskar, V. Shalini, and A. Helen Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-kappaB signaling pathway Immunobiology 216 2011 367 373
39. Z. Lu, X. Zhang, Y. Li, J. Jin, and Y. Huang TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice J Endocrinol 216 2013 61 71
40. Z.P. Hu, X.L. Fang, N. Fang, X.B. Wang, H.Y. Qian, and Z. Cao et al. Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF-kappaB system in high-fat-fed rabbits J Pineal Res 55 2013 388 398
41. V.P. Scholtes, D. Versteeg, J.P. de Vries, I.E. Hoefer, A.H. Schoneveld, and P.R. Stella et al. Toll-like receptor 2 and 4 stimulation elicits an enhanced inflammatory response in human obese patients with atherosclerosis Clin Sci (Lond) 121 2011 205 214
42. J.E. Alard, F. Gaillard, C. Daridon, Y. Shoenfeld, C. Jamin, and P. Youinou TLR2 is one of the endothelial receptors for beta 2-glycoprotein I J Immunol 185 2010 1550 1557
43. A. Ishikado, Y. Nishio, K. Yamane, A. Mukose, K. Morino, and Y. Murakami et al. Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells Atherosclerosis 205 2009 404 412
44. M.B. Taubman, J.T. Fallon, A.D. Schecter, P. Giesen, M. Mendlowitz, and B.S. Fyfe et al. Tissue factor in the pathogenesis of atherosclerosis Thromb Haemost 78 1997 200 204
45. Z. Sternberg, H. Ghanim, K.M. Gillotti, J.D. Tario Jr., F. Munschauer, and R. Curl et al. Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood Atherosclerosis 229 2013 338 347
46. M.A. Sardo, S. Campo, G. Mandraffino, C. Saitta, A. Bonaiuto, and M. Castaldo et al. Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness Clin Chem 54 2008 814 823
47. R.J. Aiello, P.A. Bourassa, S. Lindsey, W. Weng, E. Natoli, and B.J. Rollins et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 19 1999 1518 1525
48. J. Wang, F.S. An, W. Zhang, L. Gong, S.J. Wei, and W.D. Qin et al. Inhibition of c-Jun N-terminal kinase attenuates low shear stress-induced atherogenesis in apolipoprotein E-deficient mice Mol Med 17 2011 990 999
49. A.J. Muslin MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets Clin Sci (Lond) 115 2008 203 218
50. A.J. Valente, A.M. Irimpen, U. Siebenlist, and B. Chandrasekar OxLDL induces endothelial dysfunction and death via TRAF3IP2: Inhibition by HDL3 and AMPK activators Free Radic Biol Med 70C 2014 117 128
51. V. Ferreira, K.W. van Dijk, A.K. Groen, R.M. Vos, J. van der Kaa, and M.J. Gijbels et al. Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation Atherosclerosis 192 2007 283 290